An increased circulating concentration of MMP-9 has been demonstrated in patients with obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM) [38,39]. The gene discussed is MMP9; the disease is obesity due to melanocortin 4 receptor deficiency.